highperformr logo

Cytovia Therapeutics's Overview

Total employees11
HeadquartersAlpharetta
Founded

CytoVia Therapeutics, Inc. is a private, clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel gene therapies to address rare neurological diseases with high unmet medical need. The company leverages adeno-associated virus (AAV)-based gene delivery technology to target the underlying genetic cause of these disorders. Their lead program, CYTO-101, is being developed for Friedreich's Ataxia (FA) and has entered Phase 1/2 clinical trials. CytoVia aims to make a meaningful difference in the lives of patients and families affected by these devastating conditions.

Where is Cytovia Therapeutics's Headquarters?

HQ Function

The headquarters serves as the central hub for research and development, clinical operations, strategic planning, and corporate administration, driving the advancement of their gene therapy pipeline.

Notable Features:

Situated in the vibrant Avalon complex, the office likely provides modern facilities. While specific internal features are not publicly detailed, it is presumed to include specialized laboratory space conducive to gene therapy research and development alongside corporate offices.

Work Culture:

As a clinical-stage biotechnology company, the culture is likely highly collaborative, science-driven, innovative, and patient-focused. It's expected to be a dynamic and fast-paced environment dedicated to advancing cutting-edge therapies.

HQ Significance:

The Alpharetta location places CytoVia Therapeutics within the growing Atlanta metropolitan area's biotechnology cluster, offering access to a skilled talent pool, research institutions, and a supportive business environment. Avalon's amenities also contribute to a positive work environment.

Values Reflected in HQ: The choice of a modern, well-resourced location likely reflects CytoVia's commitment to innovation, scientific excellence, and providing a state-of-the-art environment for its team to develop life-changing therapies.

Location:

CytoVia Therapeutics is currently focused on its research, development, and clinical trial activities, primarily managed from its U.S. headquarters in Alpharetta, GA. While its therapeutic ambitions are global, especially for rare diseases affecting diverse populations, its direct operational footprint is concentrated in the United States. Global engagement is primarily through clinical trial sites, potential collaborations with international research institutions, and future partnerships for drug development and commercialization.

Street Address:

8000 Avalon Boulevard, Suite 202

City:

Alpharetta

State/Province:

GA

Country:

USA

Cytovia Therapeutics's Global Presence

Buying Intent Signals for Cytovia Therapeutics

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Cytovia Therapeutics

As of April 2025, Cytovia Therapeutics' leadership includes:

Koustubh 'K.J.' Ranade, Ph.D. - Co-Founder, President & Chief Executive Officer
Robert C. Longe, M.S., MBA - Co-Founder, Chief Operating Officer & Chief Financial Officer
Philippe M. Bishop, M.D. - Chief Medical Officer
Kyle T. Gamber, Ph.D. - Chief Technology Officer

Investors of Cytovia Therapeutics

Cytovia Therapeutics has been backed by several prominent investors over the years, including:

RTW Investments, LP

Executive New Hires/Exits in the Last 12 Months

Hire1
Exits0

In April 2023, CytoVia Therapeutics significantly strengthened its leadership team with the appointment of Dr. Philippe M. Bishop as Chief Medical Officer. No other major executive hires or departures have been publicly announced in the immediate last 12 months.

New Appointments:

Philippe M. Bishop, M.D., Dr. Philippe M. Bishop joined CytoVia Therapeutics as Chief Medical Officer, bringing extensive experience in clinical development for rare diseases.

Technology (Tech Stack) used by Cytovia Therapeutics

Discover the tools Cytovia Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Cytovia Therapeutics Email Formats and Examples

CytoVia Therapeutics's primary public contact email is info@cytoviatherapeutics.com. For direct communication with employees, a common professional format is likely used, such as combining the first initial and last name.

[first_initial][last]@cytoviatherapeutics.com

Format

jdoe@cytoviatherapeutics.com

Example

70%

Success rate

News and media

CytoVia Therapeutics WebsiteMarch 7, 2024

CytoVia Therapeutics Doses First Patient in Phase 1/2 Clinical Trial of CYTO-101 Gene Therapy for Friedreich’s Ataxia

CytoVia Therapeutics announced the dosing of the first patient in its Phase 1/2 clinical trial evaluating CYTO-101, an AAV-based gene therapy candidate for the treatment of Friedreich’s Ataxia....more

CytoVia Therapeutics WebsiteOctober 18, 2023

CytoVia Therapeutics Receives FDA IND Clearance and Orphan Drug Designation for CYTO-101, a Novel Gene Therapy for Friedreich’s Ataxia

The U.S. FDA cleared the Investigational New Drug (IND) application for CYTO-101 and granted Orphan Drug Designation for the treatment of Friedreich’s Ataxia....more

CytoVia Therapeutics WebsiteApril 17, 2023

CytoVia Therapeutics Appoints Philippe M. Bishop, M.D., as Chief Medical Officer

Dr. Philippe M. Bishop was appointed as Chief Medical Officer, bringing significant experience in orphan drug development and clinical expertise to the company's leadership team....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Cytovia Therapeutics, are just a search away.